Unknown

Dataset Information

0

Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging.


ABSTRACT: We report the case of a young adult which survived to anaphylactic shock caused by gadolinium-based contrast agent (GBCA) contrast agent infusion. The patient had no comorbidities and previous history of allergic reactions to contrast agents and underwent elective magnetic resonance imaging (MRI) for parotid swelling. Seven years before he received intravenous GBCA administration during an MRI, which exact chemical composition is unknown, without any allergic reaction. After intravenous injection of GBCA for MRI the patient developed anaphylactic shock, causing respiratory failure, cardiac arrest, and cardiogenic shock after return of spontaneous circulation. Because of the rarity of the described event, this report has the aim to raise awareness in the healthcare personnel of the possibility of these life-threatening adverse reactions from GBCAs also in a patient without history of allergy to contrast agents and suggest a possible clinical management of these patients.

SUBMITTER: Biagioni E 

PROVIDER: S-EPMC6961713 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging.

Biagioni Emanuela E   Coloretti Irene I   Disalvo Fabrizio F   Andreotti Alberto A   Sani Francesco F   Torricelli Pietro P   Gelmini Roberta R   Girardis Massimo M  

Radiology case reports 20200113 3


We report the case of a young adult which survived to anaphylactic shock caused by gadolinium-based contrast agent (GBCA) contrast agent infusion. The patient had no comorbidities and previous history of allergic reactions to contrast agents and underwent elective magnetic resonance imaging (MRI) for parotid swelling. Seven years before he received intravenous GBCA administration during an MRI, which exact chemical composition is unknown, without any allergic reaction. After intravenous injectio  ...[more]

Similar Datasets

| S-EPMC6939794 | biostudies-literature
| S-EPMC7793049 | biostudies-literature
| S-EPMC8885602 | biostudies-literature
| S-EPMC3888970 | biostudies-other
| S-EPMC6439394 | biostudies-literature
| S-EPMC4892988 | biostudies-literature
| S-EPMC2723097 | biostudies-literature
| S-EPMC9417687 | biostudies-literature
| S-EPMC5645056 | biostudies-literature